LANSOPRAZOL 30 MG CAP GEL DURA LIB RETARD CT BL AL PLAS TRANS X 28

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1832601780031
  • GGREM 525007105115111
  • Código de barras 7896422507431

O que a fonte publica

Detentor do registro
SANOFI MEDLEY FARMACÊUTICA LTDA.
Princípios ativos
LANSOPRAZOL
Embalagem
30 MG CAP GEL DURA LIB RETARD CT BL AL PLAS TRANS X 28
Tipo de produto
Genérico
Classe terapêutica
A2B2 - INIBIDORES DA BOMBA DE PRÓTONS

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:525007105115111
{
  "name": "LANSOPRAZOL 30 MG CAP GEL DURA LIB RETARD CT BL AL PLAS TRANS X 28",
  "holder": "SANOFI MEDLEY FARMACÊUTICA LTDA.",
  "stripe": null,
  "barcodes": [
    "7896422507431"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "525007105115111",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "10.588.595/0010-92",
  "priceRegime": "Regulado",
  "productName": "LANSOPRAZOL",
  "productType": "Genérico",
  "hospitalOnly": false,
  "presentation": "30 MG CAP GEL DURA LIB RETARD CT BL AL PLAS TRANS X 28",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "142.85",
    "icms-12": "162.33",
    "icms-17": "172.11",
    "icms-18": "174.21",
    "icms-19": "176.36",
    "icms-20": "178.56",
    "icms-21": "180.82",
    "icms-22": "183.14",
    "icms-23": "185.52",
    "icms-17.5": "173.15",
    "icms-19.5": "177.45",
    "icms-20.5": "179.69",
    "icms-22.5": "184.32",
    "icms-12-alc": "160.38",
    "icms-17-alc": "170.04",
    "icms-18-alc": "172.12",
    "icms-19-alc": "174.24",
    "icms-20-alc": "176.42",
    "icms-21-alc": "178.65",
    "icms-22-alc": "180.94",
    "icms-23-alc": "183.29",
    "withoutTaxes": "141.14",
    "icms-17.5-alc": "171.07",
    "icms-19.5-alc": "175.32",
    "icms-20.5-alc": "177.53",
    "icms-22.5-alc": "182.11"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "LANSOPRAZOL",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "196.90",
    "icms-12": "223.75",
    "icms-17": "237.24",
    "icms-18": "240.13",
    "icms-19": "243.09",
    "icms-20": "246.13",
    "icms-21": "249.24",
    "icms-22": "252.44",
    "icms-23": "255.72",
    "icms-17.5": "238.67",
    "icms-19.5": "244.60",
    "icms-20.5": "247.68",
    "icms-22.5": "254.07",
    "icms-12-alc": "221.72",
    "icms-17-alc": "235.07",
    "icms-18-alc": "237.95",
    "icms-19-alc": "240.88",
    "icms-20-alc": "243.89",
    "icms-21-alc": "246.97",
    "icms-22-alc": "250.14",
    "icms-23-alc": "253.39",
    "withoutTaxes": "195.11",
    "icms-17.5-alc": "236.49",
    "icms-19.5-alc": "242.37",
    "icms-20.5-alc": "245.42",
    "icms-22.5-alc": "251.76"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "LANSOPRAZOL"
  ],
  "therapeuticClass": "A2B2 - INIBIDORES DA BOMBA DE PRÓTONS",
  "commercialisation": {
    "year": 2025,
    "marketed": true
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1832601780031",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "A2B2",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:525007105115111"